Unilever PLC
NYSE:ULHousehold & Personal Products
+$0.57 today
- Market cap
- $139.02B
- Beta
- 0.45
- P/E (TTM)
- 25.5
- EPS (TTM)
- $1.99
- Dividend yield
- 3.84%
Volume 3.02M
Average 4.73M
UL Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Unilever PLCNYSE: UL
Accumulated OCI · Q4 FY2025 · quarter ended Dec 2025
Accumulated OCI remains negative
Q4 FY2025 Accumulated OCI was -€73.33B, compared with -€83.22B a year earlier.
Context
- Accumulated OCI amounted to 104.1% of total assets at the end of Q4 FY2025, down 0.2 pp from a year earlier.
- Accumulated OCI grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +11.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
EUR · from the balance sheet
- Latest · FY2025
- (73.33B) EUR
- Year-over-year change
- +11.9%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (73.33B) | +11.9% |
| FY2024 | 2024-12-31 | (83.22B) | -10.0% |
| FY2023 | 2023-12-31 | (75.64B) | +4.9% |
| FY2022 | 2022-12-31 | (79.56B) | -0.6% |
| FY2021 | 2021-12-31 | (79.05B) | — |
Accumulated OCI vs competitors
How UL compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +11.9% is the 2nd highest of 8, against a peer median of +0.6%.
- Accumulated OCI amounts to 104.1% of total assets for UL, versus a peer median of 9.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | -$12.9M USD | +35.5% | — | 0.1% | |
| Sep 2026 | -$158M USD | +4.2% | — | 2.0% | |
| Sep 2026 | -$1.14B USD | -0.2% | — | 5.7% | |
| Jun 2026 | -$3.39B USD | +3.5% | — | 18.2% | |
| Sep 2026 | -$3.87B USD | +0.6% | — | 23.1% | |
| Sep 2026 | -$5.41B USD | -5.4% | — | 20.3% | |
| Sep 2026 | -$12.65B USD | -4.1% | — | 9.5% | |
| Dec 2025 | -€73.33B EUR | +11.9% | — | 104.1% | |
| Peer median (excluding UL) | — | +0.6% | — | 9.5% | |
Competitors are the stored peer set for UL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.42B | 4.33B | 4.16B | 6.14B | 3.94B |
| Short-term Investments | 1.08B | 1.2B | 1.73B | 1.49B | 1.12B |
| Net Receivables | 4.47B | 4.54B | 4.94B | 5.12B | 7.67B |
| Inventory | 4.68B | 5.93B | 5.12B | 5.18B | 4.04B |
| Other Current Assets | 3.26B | 10.62B | 1.74B | 689M | 285.88M |
| Total Current Assets | 17.4B | 19.16B | 17.9B | 19.19B | 17.06B |
| Property, Plant & Equipment (Net) | 10.35B | 10.77B | 10.7B | 11.67B | 8.99B |
| Goodwill | 20.33B | 21.61B | 21.11B | 22.31B | 17.7B |
| Intangible Assets | 18.26B | 18.88B | 18.36B | 18.59B | 17.05B |
| Long-term Investments | (91M) | (293M) | 1.87B | 618M | 3.06B |
| Tax Assets | 1.47B | 1.05B | 1.11B | 662M | 1.15B |
| Other Non-current Assets | 7.38B | 6.65B | 4.21B | 6.71B | 5.44B |
| Total Non-current Assets | 57.69B | 58.66B | 57.36B | 60.56B | 53.38B |
| Total Assets | 75.1B | 77.82B | 75.27B | 79.75B | 70.44B |
| Account Payables | 8.9B | 11.1B | 10.36B | 10.26B | 16.93B |
| Short-term Debt | 6.7B | 5.23B | 4.57B | 5.88B | 2.58B |
| Tax Payables | 1.37B | 877M | 850.5M | 1.23B | 0 |
| Deferred Revenue | 2.81B | 0 | 0 | 0 | 0 |
| Other Current Liabilities | (1.72B) | 6.27B | 6.12B | 2.4B | 701.7M |
| Total Current Liabilities | 24.78B | 25.43B | 23.51B | 25.23B | 21.65B |
| Long-term Debt | 21.33B | 21.8B | 22.63B | 23.29B | 25.69B |
| Deferred Tax Liabilities | 4.53B | 4.38B | 4B | 4.34B | 3.6B |
| Deferred Revenue (Non-current) | 3.16B | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 275M | 3.45B | 3.31B | 3.17B | 596.75M |
| Total Non-current Liabilities | 30.57B | 30.69B | 31B | 31.96B | 31.21B |
| Total Liabilities | 55.35B | 56.12B | 54.5B | 57.2B | 52.86B |
| Common Stock | 92M | 92M | 88M | 88M | 84.96M |
| Retained Earnings | 46.75B | 50.25B | 47.05B | 49.72B | 44.21B |
| Accumulated OCI | (79.05B) | (79.56B) | (75.64B) | (83.22B) | (73.33B) |
| Other Stockholders Equity | (79.19B) | (79.38B) | (75.67B) | (80.39B) | (8.26B) |
| Minority Interest | 2.64B | 2.68B | 2.66B | 2.57B | 2.06B |
| Total Equity | 19.75B | 21.7B | 20.76B | 22.56B | 17.58B |
| Total Debt | 29.67B | 28.44B | 28.59B | 30.66B | 29.59B |
| Net Debt | 26.26B | 24.11B | 24.43B | 24.52B | 25.65B |
Unilever PLC
NYSE:UL
Intrinsic Alpha fair value
Locked
Current Price
$64.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.